A retrospective comparison of rituximab vs cyclophosphamide in neuromyelitis optica spectrum disorders patients

被引：0
|
作者：
Radaelli, M. [1 ]
Pensato, U. [1 ]
Sangalli, F. [1 ]
Moiola, L. [1 ]
Esposito, F. [1 ]
Greco, G. [1 ]
Colombo, B. [1 ]
Comola, M. [1 ]
Comi, G. [1 ]
Martinelli, V. [1 ]
机构：
[1] Ist Sci San Raffaele, Milan, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P844
引用
收藏
页码：434 / 435
页数：2
相关论文
共 50 条
  • [1] A retrospective comparison of Rituximab vs Cyclophosphamide in neuromyelitis optica spectrum disorders patients
    Radaelli, M.
    Pensato, U.
    Sangalli, F.
    Moiola, L.
    Colombo, B.
    Esposito, F.
    Boneschi, F. Martinelli
    Comola, M.
    Comi, G.
    Martinelli, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 405 - 406
  • [2] Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders
    Ip, Vincent H. L.
    Lau, Alexander Y. L.
    Au, Lisa W. C.
    Fan, Florence S. Y.
    Chan, Anne Y. Y.
    Mok, Vincent C. T.
    Wong, Ka-sing Lawrence
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 324 (1-2) : 38 - 39
  • [3] Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
    Marcinno, Andrea
    Marnetto, Fabiana
    Valentino, Paola
    Martire, Serena
    Balbo, Alessia
    Drago, Aurora
    Leto, Maria
    Capobianco, Marco
    Panzica, Giancarlo
    Bertolotto, Antonio
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2018, 5 (06):
  • [4] Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders
    McKeon, Andrew
    Pittock, Sean
    JAMA NEUROLOGY, 2013, 70 (09) : 1102 - 1104
  • [5] Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
    Ciron, J.
    Audoin, B.
    Bourre, B.
    Brassat, D.
    Durand-Dubief, F.
    Laplaud, D.
    Maillart, E.
    Papeix, C.
    Vukusic, S.
    Zephir, H.
    Marignier, R.
    Collongues, N.
    REVUE NEUROLOGIQUE, 2018, 174 (04) : 255 - 264
  • [6] Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
    Jade, Jui Dilip
    Bansi, Srishti
    Singhal, Bhim
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2017, 20 (03) : 229 - 232
  • [7] Psoriasis induced by Rituximab in Neuromyelitis Optica Spectrum Disorders
    Cheng, S.
    Li, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP94 - NP94
  • [8] Comparison of inebilizumab or rituximab in addition to glucocorticoid therapy for neuromyelitis optica spectrum disorders
    Lou, Chu -Yuan
    Wang, Yong
    Xing, Jia-Yuan
    Ma, Teng
    Tao, Lei
    Wang, Xiao-Tang
    Wang, Run-Sheng
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (06) : 1073 - 1078
  • [9] Neuromyelitis optica and neuromyelitis optica spectrum disorders
    Marignier, Romain
    Calvo, Alvaro Cobo
    Vukusic, Sandra
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (03) : 208 - 215
  • [10] Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders
    Novi, Giovanni
    Bovis, Francesca
    Capobianco, Marco
    Frau, Jessica
    Mataluni, Giorgia
    Curti, Erica
    Zuliani, Luigi
    Cavalla, Paola
    Brambilla, Laura
    Annovazzi, Pietro
    Repice, Anna Maria
    Lanzillo, Roberta
    Esposito, Sabrina
    Benedetti, Luana
    Maietta, Ilaria
    Sica, Francesco
    Buttari, Fabio
    Malucchi, Simona
    Fenu, Giuseppe
    Landi, Doriana
    Bosa, Chiara
    Realmuto, Sabrina
    Malentacchi, Maria
    Granella, Franco
    Signori, Alessio
    Bonavita, Simona
    Uccelli, Antonio
    Sormani, Maria Pia
    Nozzolillo, Agostino
    Gallo, Fabio
    Signoriello, Elisabetta
    Clerici, Valentina Torri
    La Gioia, Sara
    Cocco, Eleonora
    Sartori, Arianna
    Rasia, Sarah
    Cordioli, Cinzia
    Barone, Stefania
    Solaro, Claudio
    Nociti, Viviana
    Gobbi, Claudio
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 36
12345